AYTU
Price
$2.18
Change
-$0.07 (-3.11%)
Updated
Jul 13 closing price
Capitalization
23.4M
77 days until earnings call
Intraday BUY SELL Signals
DERM
Price
$6.86
Change
-$0.05 (-0.72%)
Updated
Jul 13 closing price
Capitalization
188.89M
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AYTU vs DERM

AYTU vs DERM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AYTU vs. DERM commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a StrongBuy and DERM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (AYTU: $2.18 vs. DERM: $6.86)
Brand notoriety: AYTU: Not notable vs. DERM: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 35% vs. DERM: 28%
Market capitalization -- AYTU: $23.4M vs. DERM: $188.89M
AYTU [@Pharmaceuticals: Generic] is valued at $23.4M. DERM’s [@Pharmaceuticals: Generic] market capitalization is $188.89M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 1 FA rating(s) are green whileDERM’s FA Score has 0 green FA rating(s).

  • AYTU’s FA Score: 1 green, 4 red.
  • DERM’s FA Score: 0 green, 5 red.
According to our system of comparison, DERM is a better buy in the long-term than AYTU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 3 TA indicator(s) are bullish while DERM’s TA Score has 3 bullish TA indicator(s).

  • AYTU’s TA Score: 3 bullish, 3 bearish.
  • DERM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AYTU is a better buy in the short-term than DERM.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -0.46% price change this week, while DERM (@Pharmaceuticals: Generic) price change was -4.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.88%. For the same industry, the average monthly price growth was +0.21%, and the average quarterly price growth was +13.40%.

Reported Earning Dates

AYTU is expected to report earnings on Sep 29, 2026.

DERM is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DERM($189M) has a higher market cap than AYTU($23.4M). DERM YTD gains are higher at: -11.025 vs. AYTU (-16.154). DERM has higher annual earnings (EBITDA): -1.42M vs. AYTU (-27.16M). DERM (27.2M) and AYTU (26.7M) have equal amount of cash in the bank . AYTU has less debt than DERM: AYTU (21.8M) vs DERM (25.5M). DERM has higher revenues than AYTU: DERM (64.7M) vs AYTU (56.6M).
AYTUDERMAYTU / DERM
Capitalization23.4M189M12%
EBITDA-27.16M-1.42M1,912%
Gain YTD-16.154-11.025147%
P/E RatioN/A39.08-
Revenue56.6M64.7M87%
Total Cash26.7M27.2M98%
Total Debt21.8M25.5M85%
FUNDAMENTALS RATINGS
AYTU vs DERM: Fundamental Ratings
AYTU
DERM
OUTLOOK RATING
1..100
1087
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6144
P/E GROWTH RATING
1..100
6444
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AYTU's Valuation (21) in the Other Consumer Services industry is somewhat better than the same rating for DERM (56) in the Biotechnology industry. This means that AYTU’s stock grew somewhat faster than DERM’s over the last 12 months.

DERM's Profit vs Risk Rating (96) in the Biotechnology industry is in the same range as AYTU (100) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.

DERM's SMR Rating (98) in the Biotechnology industry is in the same range as AYTU (99) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.

DERM's Price Growth Rating (44) in the Biotechnology industry is in the same range as AYTU (61) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.

DERM's P/E Growth Rating (44) in the Biotechnology industry is in the same range as AYTU (64) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUDERM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 6 days ago
76%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
87%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signal:
Gain/Loss:
DERM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSSPX59.180.05
+0.08%
Cohen & Steers Global Realty I
USNQX71.55N/A
N/A
Victory NASDAQ-100 Index
FRMPX31.03N/A
N/A
Nuveen Small Cap Growth Opp A
TGSAX10.77N/A
N/A
Templeton Global Smaller Comp Adv
HEIFX14.27N/A
N/A
Hennessy Equity and Income Investor

AYTU and

Correlation & Price change

A.I.dvisor tells us that AYTU and ZYBT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and ZYBT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
-3.11%
ZYBT - AYTU
27%
Poorly correlated
N/A
DERM - AYTU
23%
Poorly correlated
-0.72%
ETON - AYTU
23%
Poorly correlated
+1.99%
CGC - AYTU
22%
Poorly correlated
-1.15%
IMCC - AYTU
21%
Poorly correlated
-4.84%
More